Epogen
Payments companies reported to CMS as associated with Epogen. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Epogen, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Epogen
These are the largest totals companies reported as associated with Epogen. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Anjay Rastogi | Los Angeles, CA | Nephrology (Internal Medicine) | $266.48 |
| Robert Tseng | Daly City, CA | Nephrology (Internal Medicine) | $213.08 |
| Lauren Macaraeg | Daly City, CA | Internal Medicine | $213.08 |
| Warren Chang | Daly City, CA | Nephrology (Internal Medicine) | $209.33 |
| William Yang | Northridge, CA | Nephrology (Internal Medicine) | $183.63 |
| Christian Cruz | Daly City, CA | Nephrology (Internal Medicine) | $183.54 |
| Pradip Chowdhury | Montebello, CA | Nephrology (Internal Medicine) | $174.60 |
| Michael Dicus | Salinas, CA | Nephrology (Internal Medicine) | $166.16 |
| Carlos Gonzalez | Montebello, CA | Nephrology (Internal Medicine) | $156.35 |
| Kay Kyaw | Montebello, CA | Nephrology (Internal Medicine) | $154.70 |
Prescribed Epogen?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.